RAP 0.00% 20.5¢ resapp health limited

Ann: Clinical study to develop COVID-19 screening test, page-29

  1. 26,759 Posts.
    lightbulb Created with Sketch. 1732
    Well as a previous holder you should know this was always about Europe once ResAppDx got CE Mark, MSF were only doing field studies and didn't continue (hence why ResAppDx is now being evaluated in clinic in Africa after receiving regulatory approval), the project with Lockheed Martin was completed, we all know why the FDA decline the submission after taking
    10 months to review the submission.......
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.